December 15, 2021
Press & Media
Exclusive Interview of PlexBio Chairman and CEO
2019.07.31
Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd., shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in 2010. Dr. Tsao goes on to explain the company’s unique multiplexing technology based on the πCodeTM MicroDisc (‘pi-Code MicroDiscs’), and its ability to serve as a more convenient, consistent, and cost-effective alternative to next generation sequencing (NGS) in the space of precision medicine and cancer management.
For complete interview, please visit Pharma Boardroom
Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd., shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in 2010. Dr. Tsao goes on to explain the company’s unique multiplexing technology based on the πCodeTM MicroDisc (‘pi-Code MicroDiscs’), and its ability to serve as a more convenient, consistent, and cost-effective alternative to next generation sequencing (NGS) in the space of precision medicine and cancer management.
For complete interview, please visit Pharma Boardroom
